These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Zuclopenthixol in adults with intellectual disabilities and aggressive behaviours: discontinuation study.
    Author: Haessler F, Glaser T, Beneke M, Pap AF, Bodenschatz R, Reis O, Zuclopenthixol Disruptive Behaviour Study Group.
    Journal: Br J Psychiatry; 2007 May; 190():447-8. PubMed ID: 17470962.
    Abstract:
    We investigated the effects of zuclopenthixol on aggressive behaviour in patients with intellectual disabilities by randomly withdrawing it after a 6-week period of open treatment. Of the 49 patients responding to the treatment, 39 took part in a randomised withdrawal trial. The placebo subgroup (n=20) showed more aggressive behaviour as indicated by outcomes observed by external raters on the Modified Overt Aggression Scale than did the continuing subgroup (n=19). The results indicate that discontinuation of zuclopenthixolin this population leads to an increase in aggressive behaviour.
    [Abstract] [Full Text] [Related] [New Search]